Cargando…

The economics of moonshots: Value in rare disease drug development

Detalles Bibliográficos
Autores principales:	Yates, Nathan, Hinkel, Jennifer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010265/ https://www.ncbi.nlm.nih.gov/pubmed/35334152 http://dx.doi.org/10.1111/cts.13270

Ejemplares similares

Moonshots and metastatic disease: the need for a multi-faceted approach when studying atypical responses
por: De La Torre, Kristine, et al.
Publicado: (2017)

Moonshots for aging
por: Kumar, Sandeep, et al.
Publicado: (2020)

Moonshot thinking in periodontology
por: Park, Jung-Chul, et al.
Publicado: (2021)

Achieving the cancer moonshot in Africa
por: Adewole, Isaac, et al.
Publicado: (2022)

Moonshot Science—Risks and Benefits
por: Casadevall, Arturo, et al.
Publicado: (2016)

CEPI launches 100-day vaccine “moonshot”
por: Usher, Ann Danaiya
Publicado: (2022)

The Impact of the Cancer Moonshot on Cardio-Oncology Science
por: Minasian, Lori M., et al.
Publicado: (2022)

Moonshots en la educación : nuevas tecnologías y aprendizaje mixto en el aula /
por: Wojcicki, Esther
Publicado: (2016)

Exosomes in the Treatment of Pancreatic Cancer: A Moonshot to PDAC Treatment?
por: Papadakos, Stavros P., et al.
Publicado: (2022)

Moonshot!: game-changing strategies to build billion-dollar businesses
por: Sculley, John
Publicado: (2014)

Negotiating prices of drugs for rare diseases
por: Henrard, Séverine, et al.
Publicado: (2016)

A new phase of the Cancer Moonshot to end cancer as we know it
por: Singer, Dinah S.
Publicado: (2022)

Cancer Moonshot 2020: a new march of clinical and translational medicine
por: Wang, Xiangdong
Publicado: (2016)

Economic value of protected areas via visitor mental health
por: Buckley, Ralf, et al.
Publicado: (2019)

Drugs Against Rare Diseases: Are The Regulatory Standards Higher?
por: Gobburu, J, et al.
Publicado: (2016)

Reach and effectiveness of the NCI Cancer Moonshot-funded Cancer Center Cessation Initiative
por: D’Angelo, Heather, et al.
Publicado: (2022)

Biomarkers for early diagnosis of malignant mesothelioma: Do we need another moonshot?
por: Lagniau, Sabrina, et al.
Publicado: (2017)

The Power of Modeling in Emergency Preparedness for COVID-19: A Moonshot Moment for Hospitals
por: Safavi, Kyan C., et al.
Publicado: (2021)

The Cancer Moonshot Immuno-Oncology Translational Network at 5: accelerating cancer immunotherapies
por: Annapragada, Ananth, et al.
Publicado: (2023)

Journey of the Future Enterprise: How to Compete in the Age of Moonshot Leadership and Exponential Organizations
por: Calvo, Jorge
Publicado: (2020)

Identifying Options of Best Value: Use of Economic Evaluation in Public Health
por: Chen, Zhuo, et al.
Publicado: (2020)

The economic pressures for biosimilar drug use in cancer medicine
por: Cornes, Paul
Publicado: (2012)

Making Every Subject Count: A Case Study of Drug Development Path for Medication in a Pediatric Rare Disease
por: Bhattacharya, I, et al.
Publicado: (2016)

Recent Findings in the Genetics of Blood Pressure: How to Apply in Practice or Is a Moonshot Required?
por: Padmanabhan, Sandosh, et al.
Publicado: (2018)

Characteristics of patient navigation programs in the Cancer Moonshot ACCSIS colorectal cancer screening initiative
por: Coronado, Gloria D, et al.
Publicado: (2023)

The Value of Health Economics and Outcomes Research in Prosthetics and Orthotics
por: Miller, TA, et al.
Publicado: (2021)

Dissociating the Clinical Role and Economic Value of Intranasal Esketamine
por: Dadiomov, David
Publicado: (2020)

WIPO Re:Search: Catalyzing Public-Private Partnerships to Accelerate Tropical Disease Drug Discovery and Development
por: Manner, Cathyryne K., et al.
Publicado: (2019)

Estimating the number of diseases – the concept of rare, ultra-rare, and hyper-rare
por: Smith, C. I. Edvard, et al.
Publicado: (2022)

Rare Mutations in Cancer Drug Resistance and Implications for Therapy
por: Beckman, Robert A., et al.
Publicado: (2020)

Health economic modeling for Alzheimer's disease: Expert perspectives
por: Landeiro, Filipa, et al.
Publicado: (2022)

Potential of kynurenine metabolites in drug development against neurodegenerative diseases
por: Kubicova, Lenka, et al.
Publicado: (2020)

Towards a European “Cohort Moonshot”: revisiting the long-term strategy to support health research of tomorrow
por: Fagherazzi, Guy
Publicado: (2023)

A framework for stimulating economic investments to prevent emerging diseases
por: Schar, Daniel L, et al.
Publicado: (2018)

Polycentric and resilient perspectives for governing the commons: Strategic and law and economics insights for sustainable development
por: Gatto, Andrea
Publicado: (2022)

Drug and Disease Model Resources: A Consortium to Create Standards and Tools to Enhance Model-Based Drug Development
por: Harnisch, L, et al.
Publicado: (2013)

A Rare Lymphoproliferative Disease: Castleman Disease
por: Gündüz, Eren, et al.
Publicado: (2021)

The Economics of Dialysis in India
por: Khanna, Umesh
Publicado: (2009)

Foundations of complexity economics
por: Arthur, W. Brian
Publicado: (2021)

The Economics of Scientific Publishing
por: Zarif, Azmaeen
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4iralc09efr2g5bheq5kjhkitl